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Abstract.  Many cell types display two classes of 
epidermal growth factor receptor (EGFR) as judged 
from EGF binding studies;  i.e.,  a major class of low 
affinity EGFR and a minor class of high affinity 
EGFR. We have studied their respective contribution 
to the cascade of events elicited by EGF in human 
A431  carcinoma cells, using anti-EGFR mAb 2E9. 
This antibody specifically blocks EGF binding to low 
affinity EGFR, without activating receptors in intact 
cells, and thus enables us to study the effects of exclu- 
sive EGF binding to high affinity EGFR. We show 
that blocking of low affinity EGFR by mAb 2E9 has 
almost no effect on the activation of the receptor pro- 
tein-tyrosine kinase by EGF, suggesting that EGFR ki- 
nase activation occurs exclusively through the subclass 
of high affinity EGFR (5-10%).  In addition,  we pro- 
vide evidence that high affinity EGFR exists both in 
monomeric and dimeric  forms, and that cross-phos- 
phorylation of low affinity EGFR by high affinity 
EGFR may take place in dimers of both receptor 
types. 
We demonstrate that the following early cellular re- 
sponses to EGF are also unimpaired  in the presence of 
mAb 2E9:  (a) inositol phosphate production,  (b) re- 
lease of Ca  ~+ from intracellular  stores, (c) rise in in- 
tracellular pH, (d) phosphorylation of EGF on threo- 
nine residue 654,  (e) induction of c-fos gene 
expression, and (f) alteration  in cell morphology. As 
possible nonspecific side effects, we observed that the 
EGF induced Ca  2+ influx and fluid-phase pinocytosis 
were inhibited in A431  cells in the presence of mAb 
2E9.  We conclude, therefore, that the activation of the 
EGFR signal transduction cascade can occur com- 
pletely through exclusive binding of EGF to the sub- 
class of high affinity EGFR. 
PIDERMAL growth factor (EGF) is a common mitogen 
for a variety of animal cells. EGF exerts its action by 
binding  to a specific plasma membrane-located re- 
ceptor (EGFR),~ a transmembrane glycoprotein of 170 kD 
with an extracellular  EGF binding domain and an intracellu- 
lar protein-tyrosine kinase domain (9, 36). EGF/EGFR in- 
teraction  causes the activation  of this  kinase,  resulting  in 
(auto)phosphorylation of the receptor molecule, as well as 
phosphorylation of a number of cellular proteins on tyrosine 
residues (36).  Importantly,  this primary action of EGF ap- 
pears to be a prerequisite for evoking further receptor-medi- 
ated responses, since these are absent in cells expressing  a 
kinase-deficient,  but otherwise intact, EGFR (l l, 33, 35, 47). 
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I.  Abbreviations  used  in  this  paper:  BCECE  bis(carboxyethyl)carboxy- 
fluorescein;  [Ca2+]i, intracellular free calcium concentration; DSS, disuc- 
cinimidylsuberate;  EDC,  l-ethyl-3-(3-dimethyl  aminopropyl)-cartxxiiimide; 
EGFR, epidermal growth factor receptor; indo-1, indo-1 acetoxy-methyl es- 
ter; InsPn, inositol  phosphates;  PKC, protein kinase C; TPA,  12-O-tetra- 
decanoyl  phorbol-I  3-acetate. 
The elucidation of the mechanisms by which extracellular 
EGF binding activates the kinase on the intracellular  part of 
the receptor is an intriguing and as yet unresolved question. 
In highly purified  receptor preparations,  EGF/EGFR inter- 
action still results in EGFR-kinase activation.  This implies 
that in vitro no molecules other than EGF and EGFR seem 
to be involved.  Based upon this  observation, two mecha- 
nisms for receptor activation have been proposed. In the in- 
tramolecular model (27), EGF binding leads to a conforma- 
tional  change  in  the  receptor  that  is  transmitted  via the 
transmembrane  stretch to the intracellular  domain where it 
activates the kinase. In the intermolecular  model (64), EGF 
binding shifts a hypothetical  equilibrium of monomeric and 
dimeric  receptors  to  the  dimeric  form.  Dimerization  of 
receptors in this model causes activation  of the kinase. 
The action of EGF has been studied most extensively  in 
the human carcinoma cell line A431, as this cell type carries 
an unusually  high number of EGFRs; i.e., 2  x  106 recep- 
tors per cell (23). In A431 cells, like in many other cell lines, 
two classes of EGFR can be detected as judged from EGF 
binding studies: a major class of low affinity EGFR and a mi- 
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affinity being different by more than an order of magnitude. 
In A431 cells, the high affinity EGFR constitute 5-10%  of 
the total EGF binding capacity (19, 29). 
The  functional  implications  of  the  existence  of  high 
affinity and low affinity EGFRs are largely obscure, but a 
correlation  between  the  relative  number  of high  affinity 
EGFR and the activation of EGFR kinase has been estab- 
lished. Tumor promoters induce a concomitant decrease in 
high affinity EGF binding and EGF activation of the receptor 
kinase (26, 55), while the reverse is observed for cAMP treat- 
ment of PC12 cells (5). A comparison of A431 variants gave 
evidence for a similar correlation (19).  In accordance with 
these observations, the high affinity EGFRs have been impli- 
cated as the subclass through which EGF predominantly ex- 
erts its mitogenic effect (39, 40, 54). So far, a lack of tools 
for the discrimination between high and low affinity EGFRs 
has hampered the analysis of their respective roles in the 
EGF-induced  receptor  activation.  Monoclonal  antibodies 
(mAb) against growth factor receptors could provide such 
tools (20, 21, 29, 53), provided that both receptor classes are 
immunologically distinct, or that the mAb interferes dis- 
tinctly with the two classes. We have developed an mAb, 
2E9-IgG1, that fulfills the latter requirement in that it blocks 
binding of EGF to low affinity EGFR without interfering 
with EGF binding to high affinity EGFR. 
In this paper  we characterize the binding properties  of 
mAb 2E9, and study the respective contribution of high and 
low affinity EGFR to the cascade of events elicited by EGF 
in A431 cells, making use of the features of mAb 2E9.  Our 
results indicate that (a) high affinity EGFRs are the subclass 
through which tyrosine kinase activation occurs predomi- 
nantly, and (b) cross-phosphorylation of low affinity EGFRs 
by high affinity EGFRs may take place in dimers of both 
receptor types, (c) all further major early responses to EGF 
are unimpaired in the presence of mAb 2E9.  We conclude 
that the activation of the EGFR signal transduction cascade 
can occur completely through exclusive binding of EGF to 
the subclass of high affinity EGFR. 
Materials and Methods 
Materials 
EGF  (receptor grade) was from Collaborative  Research, Inc.  (Waltham, 
USA).  3,-[32p]ATP,  13Zp]orthophosphate, and  Na-125I (carrier  free)  were 
from Amersham International  (Houten,  The  Netherlands).  For  binding 
studies, EGF was labeled with Na-t251 by the chloramine T  method. La- 
beled EGF was separated from free label by ion-exchange chromatography 
on Dowex-1 (1 x  8 200; Sigma Chemical Co., St. Louis, MO). The specific 
activity  of the  1251-EGF thus obtained  varied  between  2  and  8  x  105 
cpm/ng EGE 99.5% of the labeled material was precipitable by TCA. Anti- 
body 528 was a  kind gift of Dr. J.  Mendelsohn (Sioan-Kettering Institute 
for  Cancer  Research,  New  York).  Bis(carboxyethyl)carboxyfluorescein 
(BCECF) was obtained from HSC Research Development Corp. (Toronto, 
Canada). Indo-i acetoxy-methyl ester (indo-1)  was from Molecular Probes 
(Eugene, OR). 13H]lnositol  was also from Amersham International. Fluo- 
rescein-complexon was from Eastman Kodak Co. (Tramedico, Weesp, The 
Netherlands). 
Cell Culture 
3T3 cells transfected with human EGFR sequences were a  gift of Dr.  J. 
Schlessinger (Weizmaan Institute, Rehovot, Israel).  Human keratinocytes 
were obtained from Dr. M. Ponce (University Hospital, Leiden, The Nether- 
lands). All cells were grown in DME (Gibco Europe,  Breda, The Nether- 
lands), supplemented with 7.5% fetal calf serum (Hyclone Laboratories, Lo- 
gan, LIT) and buffeted with 44 mM NaHCO3 under a 7.5% CO2 atmosphere. 
Throughout the paper, the term A431-2E9 cells refers to A431 cells that have 
been incubated with 300 nM mAb 2E9 for 30 min at 37"C before the addi- 
tion of EGF. For each set of data, the effect of antibody treatment alone was 
compared with control cells. If not specifically stated otherwise, the anti- 
body had no measurable effect on the parameter of interest. 
EGFR Antibodies 
Antibody 2E9 was chosen from a panel of monoclonal antibodies. These 
were obtained after fusion of myeloma SP2/0 cells with spleen cells from 
Ealb/c mice that had been immunized with plasma membranes from A431 
cells. The antibodies were selected on the basis of various criteria, the most 
stringent being immunoprecipitation of a functional tyrosine kinase with a 
Mr of 170 kD capable of autophosphorylation (19).  Polyclonal antiserum 
281-7 was raised in New Zealand White rabbits against a synthetic peptide 
corresponding to residues 984-995 (43) of the human EGFR. All antibodies 
used in this study were purified by affinity chromatography on a  protein 
A-Sepharose column (Pharmacia Fine Chemicals, Woerden, The Nether- 
lands).  For binding experiments, antibody was labeled as described  for 
EGE The specific activity of 1251-2E9 preparations varied between  i  and 
5  ×  104 cpm/ng, while 99.1%  of the material was TCA precipitable. 
Quantitative Binding and Binding Inhibition Studies 
Cells were grown on 24-well tissue-culture clusters (Costar, Cambridge, 
MA) to a final density of IO  ~ cells/cm  2 for A431 cells and to confluency for 
other cell types tested. After washing the cells with binding buffer (Hepes- 
buffered DME containing 0.1%  BSA), mixtures of radiolabeled and unla- 
beled ligand were added to the same medium to give a final volume of 0.5 
ml. Incubation was for 2 h at room temperature for antibody binding and 
at 0°C for EGE After this, cells were washed five times with PBS, dissolved 
in 1 M NaOH, and eell-associatnd radioactivity was measured in a ~,-counter. 
Nonspeciffe binding was determined using a  500-l,000-fold molar excess 
of unlabeled ligand. Data analysis, using the program LIGAND, was per- 
formed as described (6). 
For  binding  inhibition assays, cells  were  preincubated  with  the  first 
ligand for 60 min at 0°C in the case of EGF or for 2 h at room temperature 
in the case of antibody, after which period radiolabeled second ligand was 
added to the same medium to give a  final volume of 0.5 ml. 
US-EGF/EGFR Cross-linking 
A431 cells, grown on 19-cm  2 tissue culture dishes (Costar) were pretreated 
for 30 min at 37°C with binding buffer in the presence or absence of 300 
nM mAb 2E9.  The cells were subsequently chilled on ice,  1251-EGF (sp 
act,  180,000 cpm/ng) was added to a final concentration of 20 ng/ml with 
or without 1 t~g/ml of unlabeled EGE After incubation for 60 min at 4°C, 
cells were washed three times with ice-cold PBS and incubated for a further 
15 min at 4°C in a  1 mM solution of disuccinimidyisuberate (DSS; Pierce 
Chemical Co., Rockford, IL) in a 1:1 mixture of DMSO and PBS. The reac- 
tion was stopped by adding glycine (final concentration 100 mM, at pH 7.4) 
and incubated for 5 min at 4"C. After this, the cells were washed with PBS, 
scraped off the substratum with a rubber policeman, and pelleted for 2 rain 
at 2,000 g. The cells were lysed in RIPA buffer (36) and insoluble material 
was removed by centrifugation at 15,000 g for 10 min at 4°C. The soluble 
fraction was boiled in Laemmli sample buffer and applied to a linear %9% 
gradient polyacrylamide gel. An autoradiograph of the gel was made using 
Kodak X-AR5 film. 
lmmunoprecipitation of  EGFR from Cell Lysates 
After incubation with ligand, ceils were washed and lysed by scraping in 
500/.d RIPA buffer. The tysates were clarified by centrifugation for 15 min 
at 15,000 g. 20/~g 281-7-IGG bound to protein A-Sepharose (Pharmacia Fine 
Chemicals) was added to the lysates. The precipitate was washed once with 
buffer containing 20 mM Tris-HCl, pH 7.4, 500 mM NaCI, 0.5%  Triton 
X-100, and twice with the same buffer containing 150 mM NaCI. For SDS- 
gel electrophoresis the precipitates were boiled in Laemmli sample buffer 
and applied directly to the gel. 
EGFR Protein-l~yrosine  Kinase Activity Measurements 
in Intact Cells 
Cells grown to subconfluency (100,000 cells/cm  2) on 35-ram dishes (Cos- 
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DME for 16 h. Where indicated, antibody, EGF (50 ng/ml), or buffer were 
added to the same medium. After incubation, EGFR was immunoprecipi- 
tared as described above, and the precipitates were applied to a linear 5-15 % 
SDS-polyacrylamide gel. The receptor band was localized in the dried gel 
by autoradiography on Kodak X-AR 5 films, cut out with a razor blade, and 
homogenized in 50 mM NI-hHCO3 containing 0.2% SDS and 2%/3-mer- 
captoethanol. After incubation for 5 min at  100°C and 120 min at 20"C, 
the gel homogenate was spun at 10,000 g for 2 min and the suparnatant was 
collected. After addition of 20/~g RNase (Sigma Chemical Co., St. Louis, 
MO) and incubation for 15 rain on ice, TCA was added to a final concentra- 
tion of 12.5%.  The TCA precipitates were collected by centrifugation at 
12,000  g for 5 min and washed once with pure ethanol. The pellets were 
dried under a stream of N2, resuspended in a small volume of formic acid, 
and an aliquot of each sample was hydrolyzed in 6 M HCI at ll0°C for 60 
min. The hydrolyzed samples (,M,000 cpm as determined by Cerenkov radi- 
ation) were applied to plastic foil thin-layer cellulose plates 5577; E. Merck, 
Darmstadt,  FRG) together with 60 ng each of unlabeled phosphoserine, 
phosphothreonine, and phosphotyrosine. Two-dimensional electrophoresis 
at pH 1.9 and 3.5 were as described by Cooper et al. (17). Phosphoamino 
acids were detected by spraying with 0.25% ninhydrin in acetone. After au- 
toradiography, the phosphoamino spots were cut from the plate using a pair 
of scissors and radioactivity  was measured using Dynagel (Baker Chemical 
Co., Deventer, The Netherlands) in a  liquid scintillation counter. 
Surface lodination and EGFR Cross-linking 
in Intact Cells 
A431 cells, grown to subconfluency in 19-cm  2 dishes (Costar) were washed 
with PBS and surface iodinated by the lactoperoxidase method exactly as 
described (16), using 300/~Ci of carder-free Na-t25I. The reaction was ter- 
minated by washing the cells extensively with DME containing 0.1% BSA, 
and a further incubation in this medium for 30 min at room temperature. 
Some of the dishes were subsequently incubated with 300 nM mAb 2E9 
for 30 rain at 37°C.  The cells were cooled to 0°C, after which EGF was 
added to the same medium and the cells were incubated for an additional 
30 rain. After washing the cells, a 10 mM solution of l-ethyl-3-(3-dimethyl 
aminopropyl)-carbodiimide (EDC) in PBS containing 1 mM glucose was 
added to the cells, and cross-linking was allowed to proceed for 30 rain at 
30°C. Cells were washed three times with PBS and lysed in 0.5% Triton 
X-100, 150 mM NaCI, 5 mM EDTA,  1 mM PMSF, 20 mM Tris-HCI, pH 7.4. 
EGFR was immunoprecipitated from the lysates using antiserum 281-7, 
and the immunoprecipitates were subjected to electrophoresis on a 4-10% 
linear gradient SDS-polyacrylamide gel. 
Polyphosphoinositide Breakdown 
Polyphosphoinositide breakdown was determined in A431 and A431-2E9 
cells as inositol phosphates (InsPn) accumulation in the presence of LiCI 
as described by Tilly et al. (59). 
[CaZ÷]i and pHi Measurements 
Determination  of intracellular  free  Ca  2+  concentration  ([Ca2+]i)  using 
indo-1, and pHi using BCECF were determined as described by Moolenaar 
et al. (47). 
Tryptic Phosphopeptide Mapping of the EGFR 
Cells grown to subconfluency  (150,000 ceils/cm  2) on 35-mm dishes (Costar) 
were labeled with 1 mCi/ml [32Plorthophosphate  (Amersham International) 
in phosphate-free DME for 16 h. The cells were preincubated with mAb 
2E9 in the same medium. EGF (50 ng/ml) or buffer were added to this 
medium for an additional 30 rain. After this, cells were lysed in RIPA buffer 
(150 mM NaCI, 20 mM Tris-HCl, pH 8.0, 10 mM NaH2PO4, 5 mM EDTA, 
0.1 mM Na3VO4, 1% NP-40, 1% sodium desoxycholate, 0.1% SDS, 1 mM 
PMSE 100 KIU/ml Aprotinin). The EGFR were precipitated using antise- 
rum 281-7 and protein A-Scpharose beads (Pharmacia Fine Chemicals). 
The precipitate was applied to a linear 5-15 % SDS-polyacrylamide gel. The 
receptor band was localized in the dried gel by autoradiography, cut out with 
a  razor blade, and homogenized in 50 mM NI-I4HCO3, 0.2%  SDS, 2% 
/3-mercaptoethanol. After incubation for 5 min at  100°C and  120 min at 
20°C, the homogenate was spun at 10,000 g for 2 min and the supernatant 
was collected. After addition of 20/~g RNase (Sigma Chemical Co.) and 
incubation for 15 min on ice, TCA was added to a final concentration of 
12.5%. The TCA precipitates were collected by centrifugation at 12,000 g 
for 5 min and washed once with pure ethanol. The pellets were dried under 
a stream of N2. By this procedure, '~70% of the counts present in the gel 
were recovered as measured by Cerenkov radiation. Samples were subse- 
quently treated with performic acid and trypsin as described by Beemon and 
Hunter (2). Tryptic phosphopeptides were separated on thin-layer cellulose 
plates (E. Merck; 5716) by electrophoresis (pH 8.9 at 1,000 V) for 20 rain 
in the first dimension, followed by ascending chromatography in N-butanol/ 
pyridine/acetic acid/H20 (75:50:15:60). 
c-fos Expression 
A431 cells, grown to 80% confluency, were washed and the medium was 
replaced by serum-free DME. 2 h later, agonists were added. 30 min later, 
the medium was aspirated and the cells were lysed in  5.7  M  guanidin 
isothiocyanate. RNA was isolated according to Chirgwin et al.  (14),  and 
quantitated by absorption at 260 nM. 20-#g aliquots were electrophoresed 
on a 0.7 % agarose gel containing 2.2 M formaldehyde, after which the RNA 
was transferred to nitrocellulose. Hybridization was in 50% formamide with 
a nick-translated probe (sp act 5  x  l0  g clam  , 106 cpm/ml), for 16-20 h. Fi- 
nal washes were with 0.1 SSC and 0.1% SDS at 55°C. Autoradiography was 
on Kodak X-Omat XAR5 film. 
Fluid-phase Pinocytosis 
A431  and  A431-2E9  cells,  at  subconfluency on  six-well tissue-culture 
clusters (Costar) were incubated with fluorescein-complexon (1 mg/ml) in 
Hepes-buffered  DME containing 0.1% BSA. EGF (50 ng/ml) was added and 
at various time intervals the cells were washed five times in ice-cold PBS, 
followed by lysis in 2 ml of 0.05%  Triton X-100 containing PBS. The lysis 
buffer was carefully aspirated and the amount of fluorescein-complexon 
measured by emission at a wavelength of 560 nm and an excitation wave- 
length of 500 nm in a Perkin-Elmer Corp. (Norwalk, CT) 3000 fluorimeter. 
Results 
2E9-IgG1 Binds V~th a 1:1 Stoichiometry to the 
Protein Core of the EGFR 
Several  aspects of the production and biological properties 
of mAb 2E9-IgG1 have been described elsewhere (19-21). 
It is one of a panel of anti-EGFR mAbs obtained after fusion 
of SP2/0 myeloma cells with spleen cells of Balb/c mice im- 
munized with plasma membrane vesicles of A431 cells. Im- 
munoprecipitation experiments using A431 cells, metaboli- 
cally labeled with psS]methionine in the presence or absence 
of the glycosylation inhibitor tunicamycin, showed that mAb 
2E9 recognizes the protein core of the receptor, since it pre- 
cipitated the 130-kD nonglycosylated  form (56) of this mole- 
cule (not shown). 
To quantitate the binding properties of mAb 2E9, it was 
purified by affinity chromatography, and labeled with ~25I. 
At 20°C,  ~25I-2E9 binding to A431 cells was analyzed ac- 
cording  to  Scatchard  (52)  as  described  in  Materials and 
Methods. Binding equilibrium, as determined by measuring 
incubation time-dependent association of radiolabeled anti- 
body, was reached after 60 min at room temperature (not 
shown). The Scatchard plot yielded a straight line (Fig.  1), 
indicating that the antibody binds with an apparent dissocia- 
tion constant (Kd) of 32 nM to a number of antigenic deter- 
minants that roughly equals  the  number of EGFR  (2  x 
106/cell) (23).  This indicates a  l:l  stoichiometry for 2E9- 
EGFR binding. 
An important property of mAb 2E9 was revealed by mea- 
suring the effect of preincubating A431 cells with EGF or 
mAb 2E9 on the subsequent binding of either ligand. Prein- 
cubation with mAb 2E9 blocks EGF binding (Fig. 2 A) and, 
vice versa, preincubation with EGF blocks mAb 2E9 bind- 
ing (Fig.  1) to intact A431 cells. Experiments in which the 
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Figure 1. Scatchard graph ofmAb 2E9 binding to intact A431 cells. 
Cells were incubated at 20*(2 for 120 min with a constant amount 
of nSI-labeled antibody together with increasing amounts of unla- 
beled antibody. Cell associated radioactivity was measured and 
Scatchard analysis was performed as described in Materials and 
Methods. Nonspecific binding was determined using a 1,000-fold 
excess of unlabeled antibody and did not exceed 5 %. Inset shows 
saturation curve of  the data. The open circles show Scatchard analy- 
sis of mAb 2E9 binding after preincubation with 50 ng/ml of EGE 
order of addition of the ligands was reversed, showed that 
neither EGF nor mAb 2E9 caused a significant change in the 
dissociation rate of either ligand (not shown).  The former 
observation indicates that mAb 2E9 is directed against an an- 
tigenic determinant close to or at the binding domain for 
EGF. When similar experiments were carried out on p-for- 
maldehyde-fixed A431 cells-a treatment that does not inter- 
fere with the specific binding of either ligand (7, 62)-the 
results were strikingly different. As  before, preincubation 
with mAb 2E9 did inhibit EGF binding under these condi- 
tions, but preincubation with EGF now did not inhibit mAb 
2E9 binding. This indicates that EGF and mAb 2E9 recog- 
nize different epitopes on the EGFR, and that EGF does not 
inhibit mAb 2E9 binding due to direct binding competition. 
mAb 2E9 Blocks EGF Binding to Low-a:~nity 
Receptors Only 
During  the  competition  studies,  the  following  intriguing 
phenomenon was observed: the extent of inhibition of EGF 
binding by mAb 2E9 depended upon the concentration of the 
growth factor,  such that at low EGF concentrations (<0.1 
nM) saturating doses of mAb 2E9 inhibited binding by only 
60-70%, while at higher EGF concentrations (>1.0 nM) in- 
hibition was as high as 90-95%.  An explanation for this 
phenomenon was found in Scatchard analysis of EGF bind- 
ing data to A431 cells with or without preincubation with a 
saturating  amount of mAb  2E9  (300  nM  for  120 min  at 
20°C).  As shown in Fig. 2 A  (solid circles),  this analysis 
yielded a curvilinear graph, indicating the presence of two 
receptor classes in A431 control cells with different affinities 
for EGE Obviously, it is difficult to determine accurately the 
number of high affinity binding sites from this graph, due to 
the very small initial curvature (see also Discussion). Using 
the program LIGAND (6), the estimated values for the num- 
ber of receptors of both affinity classes and their affinity for 
EGF were 75,000 receptors, with an apparent Kd of 0.7 nM, 
and  1,900,000 receptors, with a Kd of 8.5  nM.  Preincuba- 
tion of A431 cells with mAb 2E9 followed by Scatchard anal- 
ysis of J2~I-EGF binding yielded a  linear Scatchard graph 
(Fig. 2 A, open circles)  with a slope identical to the initial 
part of the graph in control cells, indicating a specific block 
of EGF binding to low affinity receptor sites only. The num- 
ber of receptors remaining was 90,000, with an apparent Kd 
of 0.9 nM. 
The specific block of EGF binding to the low affinity sub- 
class by mAb 2E9 was not restricted to A431 cells. The anti- 
body had the same effect on HeLa cells (Fig. 2 B), on human 
keratinocytes, and on 3"1"3 cells transfected with the wild- 
type human EGFR (line DHER  14,  obtained from Dr.  J. 
Schlessinger, Weizmann Institute) (data not shown), even af- 
ter preincubation with supersaturating rnAb 2E9 concentra- 
tions (1,200 nM; data not shown). Furthermore, a prolonged 
incubation with mAb 2E9 (24 h) did not alter the amount of 
high affinity sites as compared to a  1-h preincubation (data 
not shown), indicating that mAb 2E9 does not abolish a pos- 
sible long-term recruitment of high affinity from low affinity 
receptors. When the same experiments were done with an- 
other anti-EGFR mAb, 528-IGG1, which blocks EGF bind- 
ing to p-formaldehyde-fixed A431 cells by >95 % (51), EGF 
binding to both receptor classes was blocked almost com- 
pletely (not shown).  This antibody, which is also directed 
against the protein core of the receptor (28), does not com- 
pete with mAb 2E9 for binding (not shown), indicating that 
the antibodies are directed against different epitopes. 
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Figure 2. Scatcbard analysis of EGF binding to A431 cells (A), HeLa cells (B), and 3T3-IV cells (C, see text). Cells were either untreated 
(solid circles) or pretreated with 300 nM mAb 2E9 (open circles) for 120 rain at room temperature. Subsequently, increasing concentrations 
of EGF were allowed to bind for 120 min at 0°C. Scatcbard analysis of the amount of EGF bound to the cells was performed as described 
in Materials and Methods. The solid squares in C represent cells pretreated with antibody 2E9 at a concentration of 30 nM. 
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phosphorylation in intact, 32p_ 
labeled A431 cells. A431 cells, 
labeled overnight with  [a2p]_ 
orthophosphate  were  treated 
(where indicated) with  mAb 
2E9 for 30 rain at 37°C, fol- 
lowed  by  (where  indicated) 
EGF for 5 rain at 37°C. Subse- 
quently, the cells were lysed in 
RIPA buffer and  the  EGFR 
was  immunoprecipitated  us- 
ing antiserum 281-7. (Lej~)  Au- 
toradiograph of the irnmuno- 
precipitates analyzed by SDS 
gel  electrophoresis.  (Right) 
Phosphoamino  acid  analysis 
of the EGFR eluted from the 
gel and analyzed as described 
in  Materials  and  Methods. 
Concentrations  used  were: 
EGF, 50 ng/ml; mAb 2E9, 50 
#g/ml.  C, Control. (B) Anal- 
ysis of the relative amount of 
receptors exposed to the cell 
surface. A431 cells, grown to 
subconfluency were incubated 
overnight with 20 #Ci/rnl  of 
PS]methionine in methionine- 
free DME supplemented with 
1%  FCS. Half of the  cells 
were  subsequently incubated 
with 100 nM of antibody 528 
for 60 min at 0°C. The cells 
were washed, lysed in RIPA, 
and the 528-EGFR complex 
was immunoprecipitated with 
rabbit anti-mouse IgG coupled 
to protein A-Sepharose.  In a 
parallel experiment, the cells 
were  lysed before  mAb  528 
addition and immunoprecipi- 
tation. (a) An autoradiograph 
of the immunoprecipitates  anal- 
yzed by SDS gel electrophore- 
sis. (Lane 1) Surface-exposed 
receptors; (lane 2) receptors in 
total cell lysate. (b) Densito- 
metric scan of the autoradio- 
graph depicted in a. 
That the blocking of EGF binding to low affinity receptors 
approached 100% was demonstrated in HeLa cells pretreated 
with the tumor promoter 12-O-tetradecanoyl phorbol-13-ac- 
etate (TPA), which in these cells abolishes high affinity EGF 
binding completely (55), as well as in 3T3 cells transfected 
with EGFR lacking almost the entire intracellular domain 
(3T3-IV cells) which display only one low affinity subclass 
(44). In both cases, preincubation with increasing amounts 
of mAb 2E9 led to a  parallel shift of the Scatchard graph 
until,  at saturating concentrations of antibody, EGF bind- 
ing was no longer detectable (shown for 3T3-IV cells in Fig. 
2  C). 
Activation of  EGFR Protein-~rosine Kinase Occurs 
through High Affinity EGFR 
Several authors (39, 40, 54) have hypothesized that the high 
affinity receptor subclass is the major EGF signal transduc- 
ing  system.  We  could  test  this  hypothesis  by  measuring 
receptor activation by EGF in  intact cells pretreated with 
mAb 2E9. A431 cells were labeled to equilibrium with ~2p 
and preincubated for  1 h  with 300 nM mAb 2E9.  Subse- 
quently, EGF (50 ng/ml) was added to the same medium and 
the cells were incubated for various time intervals. After this 
the receptor was isolated and its phosphoamino acid content 
Defize et aL High Affinity EGFR-induced Signal Transduction  2499 Table L Quantitation of  Phosphorylation and Phosphoamino Acid Analysis of  EGFR Isolated  from ~2p-labeled  A431 Cells 
Relative amount of cpm in phosphoamino acids 
Total 32p incorporated 
Incubation  in EGFR  Phosphoserine  Phosphothreonine  Phosphotyrosine 
Control  12,827  61.3  36.3  2.3 
EGF  27,728  58.3  25.5  16.1 
mAb 2E9  17,745  64.4  33.8  1.8 
2E9/EGF  22,748  58.8  31.8  9.4 
EGFR protein immunoprecipitated from 32P-labeled A431  cells was treated as described in Materials and Methods and the legend to Fig.  3.  Total amount of 
counts per minute incorporated into receptor protein was measured in ethanol-washed TCA precipitates  of EGFR material eluted from the SDS gel shown in Fig. 
3. The relative amount of radioactivity  in the three phosphoamino acids (phosphoserine, phosphothreonine, and phosphotyrosine) was determined by cutting out 
the phosphoamino acid spots from the thin-layer plate shown in Fig. 3 after scraping the surrounding areas. The isolated phosphoamino acid samples were counted 
with liquid scintillation  fluid in a liquid scintillation  counter. For background subtraction, several regions of the thin-layer plate were cut out and counted similarly. 
The data presented in the table are from a single experiment, which was repeated several times with essentially the same results. 
was determined by two-dimensional analysis as described in 
Materials and Methods. It is clear from the autoradiograph 
of the SDS gel (Fig. 3 A, left panel) that a 1-h incubation with 
mAb 2E9 leads to enhanced incorporation of 32p into the 
receptor.  However,  this  incorporation  is  not  on  tyrosine 
residues (Fig. 3 A, right panel). 
Pretreatment with mAb 2E9 leads to a reduction in the ac- 
tivation of EGFR by EGF as measured by receptor tyrosine 
phosphorylation. However, this reduction is relatively small 
as compared to the reduction in the number of receptors ac- 
cessible to EGF after mAb 2E9 pretreatment. Quantitative 
data, obtained by counting the individual phosphoamino acid 
spots in a/~-counter are presented in Table I. While, after 
mAb 2E9 pretreatment, binding of EGF to its receptor is 
blocked by ~95 %, receptor tyrosine (auto)phosphorylation 
induced by the growth factor is only reduced by '~30%. 
Time-course analysis showed no effect of mAb 2E9 on the 
rapidity  of the  EGF-induced EGFR tyrosine (auto)phos- 
phorylation (not shown). In antibody-pretreated as well as in 
control cells, this was maximally induced 1 min after the ad- 
dition of EGE From these data, we conclude that EGFR acti- 
vation, as measured by receptor autophosphorylation, oc- 
curs predominantly if not exclusively through high affinity 
binding sites. 
To establish the amount of EGFR exposed at the cell sur- 
face as a  fraction of the total receptor population, we in- 
cubated [35S]methionine-labeled  A431 cells at 0°C (to pre- 
vent internalization) with 100 nM of antibody 528 (39) in 
order to occupy all membrane-exposed receptors.  Subse- 
quently, the cells were washed, lysed in RIPA buffer, and the 
528-EGFR complexes immunoprecipitated from the lysates. 
In a parallel experiment, cells were lysed, followed by incu- 
bation with antibody 528,  and immunoprecipitation.  The 
precipitates were analyzed by SDS gel electrophoresis and 
autoradiography. An autoradiograph of this experiment is 
shown in Fig. 3 B, together with a densitometric scan. From 
this, we calculate that 30% of the total receptor population 
is localized at the cell surface, in accordance with earlier es- 
timates (10, 42). Thus, high affinity EGFRs, which represent 
"-5-10%  of membrane-exposed receptors,  constitute only 
~2-3 % of the total receptor population. However, estimates 
about the fraction of EGFRs that becomes phosphorylated on 
tyrosine residues after EGF treatment vary from 20 (refer- 
ence 15) to 35% or more (58) of the total receptor popula- 
tion, and thus receptor (auto)phosphorylation does not occur 
exclusively on high affinity receptors.  Activation of EGFR 
protein-tyrosine  kinase  however,  occurs  predominantly 
through the high affinity subclass (see above). Since our data 
indicate that low affinity receptors have to be (auto)phos- 
phorylated in response to EGF, this indicates that phosphory- 
lation of low affinity receptors  occurs through activation  of 
high affinity receptors,  possibly via cross-phosphorylation. 
EGFR Dimerization Is EJ~ciently Driven Through 
High Affinity EGF Binding 
Cross-phosphorylation of low affinity by high affinity recep- 
tors implies a physicochemieal interaction between the two 
molecules. The EGF driven formation of receptor dimers as 
described by Cochet et al. (16) could well be a reflection of 
this process. To test whether dimerization between high and 
low affinity receptors indeed occurs, A431 cells were surface 
labeled with ~I using lactoperoxidase as described by Cocbet 
et al. (16). The labeled cells were treated with mAb 2E9, fol- 
lowed by EGF at 0°C, and possible receptor-receptor com- 
plexes were cross-linked with EDC as described (16). Cells 
were lysed in RIPA buffer and EGFR was immunoprecipitated 
as described in Materials and Methods. The immunoprecipi- 
tates were analyzed by SDS gel electrophoresis and autora- 
diography. 
As shown in Fig. 4 A, the antibody itself does not cause 
receptor  dimerization.  Furthermore,  receptor  dimers  are 
still formed in response to EGF in mAb 2E9-pretreated cells 
albeit at a reduced rate, implying that receptor dimerization 
is driven by EGF even when it binds to high affinity receptors 
only. This result however, could also imply that dimers are 
formed exclusively in the high affinity subpopulation. To test 
this possibility, we measured the amount of receptor oligomers 
cross-linked to  ~2q-EGF before and after mAb 2E9 treat- 
ment. A431 cells were preincubated with 300 nM mAb 2E9, 
followed by an incubation with 12q-EGF at a concentration 
of 20 ng/ml at 4°C to prevent EGF-induced receptor inter- 
nalization. After extensive  washing,  receptor/t~I-EGF com- 
plexes were cross-linked with the bivalent reagent DSS as de- 
scribed by Fanger et al. (24). The cells were taken up in SDS 
sample buffer and applied to a 7-9%  linear gradient poly- 
acrylamide gel. Fig. 4 B shows an autoradiograph of such a 
gel. In cells not pretreated with antibody, two labeled com- 
plexes were  found, which had an Mr of 170  (monomeric 
form) and 325 kD (dimeric form), respectively, in accordance 
with the data of Fanger et al. (24) and Cochet et al. (16). In 
parallel dishes, where a high amount of unlabeled EGF was 
The Journal of Cell Biology, Volume 109,  1989  2500 Figure  4.  (A)  EGF-induced 
EGFR  dimerization  in  intact, 
surface-iodinated  A431  cells. 
A431  cells  were  surface  iodi- 
hated  exactly  as  described  by 
Cochet et al.  (16). Subsequent- 
ly, the cells were treated (where 
indicated) with mAb 2E9 for 30 
min at  37°C.  After this,  EGF 
was  added  (where  indicated) 
and ceils  were incubated  for a 
further  30  min  at  0°C.  Cells 
were washed  and  treated  with 
EDC  (see  text)  for 30 min at 
300C.  Subsequently,  the  cells 
were lysed in RIPA buffer,  the 
receptor  complexes  were  im- 
munoprecipitated using antise- 
rum 281-7 and subjected to SDS 
gel  electrophoresis  on  a  7% 
polyacrylamide gel with a  5 % 
stacking gel.  The gel was dried 
and autoradiographed on Kodak 
X-AR 5 film. M, EGFR mono- 
mer  (Mr  170  kD),  D,  EGFR 
dimer (Mr 325 kD). (B) Cross- 
linking  of '2SI-labeled EGF to 
untreated (-2E9) or mAb 2E9- 
pretreated  (+2E9)  A431 ceils. 
After pretreatment for 30 min at 
37°C  with  300  nM  mAb 2E9 
(where indicated), cells were in- 
cubated with  125I-EGF (20 rig/ 
ml; sp act, 3  x  105 cpm/ng) for 60 rain at 4°C. To some dishes a 50-fold excess of unlabeled EGF was added (+ lanes).  After a 60-min 
incubation at 4°C, EGF/EGFR complexes were cross-linked with DSS as described in Materials  and Methods. The cross-linked complexes 
were separated  on a 7-9% linear polyacrylamide gel.  Automdiography was with Kodak XAR-5 film.  Exposure time was 50 h at -70°C. 
added, essentially no radioactivity was found in the gel, indi- 
cating a high specificity of labeling. After preincubation with 
mAb 2E9 both monomeric and dimeric receptor forms are 
still  observed.  These  results  demonstrate  clearly  that  the 
high affinity receptor fraction does not represent exclusively 
dimers,  but contains also monomers. 
Intraceltular Free Ca  z+ 
Many mitogens,  including EGF, evoke a  rapid (within  sec- 
onds  after  addition)  rise  in the  [Ca2+]~. It has been  estab- 
I 
0 
x  , 
Stimulation of Polyphosphoinositide Breakdown  ~ s 
Among the earliest detectable secondary responses to the ac-  - 
tivation of a  wide variety of membrane receptor systems is 
<  the activation of phospholipase C, resulting in the hydrolysis 
of polyphosphoinositides. As a consequence at least two im-  ~  4  o 
portant second messengers are produced; i.e.,  inositol tris-  ~- 
phosphate and 1,2-diacylglycerol. Although quantitative dif- 
ferences are found for different hormones and different cell 
types, EGF is no exception to this rule (4, 8). Here we deter-  ~  a 
Z 
mined the activation of phospholipase C by determining the  t~ 
accumulation of InsPn in the presence of LiCl (8).  A  dose-  ~.a 
response curve of the EGF-induced InsPn accumulation is 
shown  in  Fig.  5.  Half-maximal  stimulation  occurred  at  5 
ng/ml of EGE In A431-2E9 cells (see Materials and Methods), 
InsPn formation was slightly decreased without a significant 
change in the shape of the dose-response curve, showing that 
EGF occupation of high affinity sites alone is sufficient for 
the activation of phospholipase C. 
I  I  I 
0  5  10  50 
(EGF)  ng/ml 
Figure 5.  InsPn formation in A431  and  A431-2E9 cells.  Myo- 
[3H]inositol-labeled  A431 and A431-2E9 cells were treated  with 
the indicated concentrations of EGF for 30 min in the presence of 
10 mM LiCI.  Formation of InsPn was determined as described 
(59).  Solid  circles represent  A431 cells; open circles,  A431-2E9 
cells.  Data are expressed  as mean  ±  SEM (n  =  3). 
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Figure 6. [Ca]i measurements. A431 (A and B) and A431-2E9 (C) 
cells, loaded with indo-1 were treated with EGF (50 ng/ml) and 
Ca  2+ (4 mM) as indicated, in the presence (A and C) or absence 
(B)  of Ca  2+.  Indo-1 fluorescence  was  continuously  monitored 
using a fluorimeter. Cells in B were treated with 4 mM EGTA be- 
fore EGF addition. 
lished that in the majority of cases this is primarily due to 
the release of Ca  2÷ from intracellular stores (4) evoked by 
the production of inositol trisphosphate. In a variety of cell 
lines it has been found that the EGF effect is largely depen- 
dent on the presence of Ca  2÷ in the extracellular medium 
(46). Hepler et al. (32) and Wheeler et al. (60) showed that 
in A431 cells the EGF-induced Ca  2÷ signal is biphasic, con- 
sisting of a small, transient release of Ca  2+ from intracellu- 
lar stores accompanied by a large, prolonged influx from the 
extracellular medium. 
A431  cells  were  labeled  with  indo-1,  a  fluorescent dye 
which allows detection of minor changes in [Ca2÷]:. In con- 
trol ceils, EGF addition resulted in a broad and prolonged 
response (Fig. 6 A) in accordance with previous results (32, 
46, 60). Addition of EGF in Ca2÷-free medium resulted in a 
single,  transient peak (Fig.  6 B). When extra Ca  2÷ was added 
to these cells, a second peak of [Ca2+]~ increase due to influx 
was observed (Fig.  6 B),  in accordance with the results of 
Wheeler et al. (60).  EGF addition to A431-2E9 cells (Fig. 
6  C) resulted in a Ca  2÷ signal much like that measured in 
the presence of EGTA (Fig. 6 B). The rise in [Ca2*]~ is rapid 
and transient, suggesting that mAb 2E9 does not impair Ca  2÷ 
mobilization, but causes a block of Ca  2+ influx. In line with 
this assumption, addition of Ca  2÷ did not have any effect on 
[Ca2+]~ (Fig. 6 C). Our results thus indicate that Ca  2÷ mobili- 
zation is unaffected when EGF binding to low affinity EGFR 
is blocked by mAB 2E9. Whether the observed inhibition of 
EGF induced Ca  2+ influx by mAb 2E9 is a nonspecific side 
effect of the antibody, or results from a specific 2E9-EGFR 
interference, remains to be determined. 
lntraceUular pH (pHi) 
Mitogenic stimulation of quiescent cells under bicarbonate- 
free conditions leads to a rapid and sustained increase in pHi, 
mediated by activation of the amiloride sensitive Na+/H  + ex- 
changer (45).  A  change in pH: evoked by EGF can be op- 
timally measured in  A431  cells when  the cells have been 
incubated under serum-free conditions at a relatively low ex- 
ternal  pH (pHo)  (6.8)  for 24 h  (reference 20,  unpublished 
observations). Incubation at pH 6.8 does not influence bind- 
ing of mAb 2E9 (not shown).  Addition of EGF to control 
cells leads to an increase in pH, of '~0.1 U (Fig. 7 A). EGF 
treatment of A431-2E9 cells leads to a comparable increase 
in pH~ as shown in Fig. 7 B. This contrasts an earlier obser- 
vation (20),  in which 2E9 was reported to block the EGF- 
induced  pH~ response  at pHo 7.2.  We  do  not  know  what 
caused the inhibitory effect at that time, but despite numer- 
ous efforts, we are not able even in control cells to measure 
any pH, change at this pHo anymore. Clearly, at least at pHo 
6.8, occupation of high affinity receptors by EGF is sufficient 
to activate the Na+/H  ÷ exchange system in A431  cells with 
similar kinetics as when the total receptor population is avail- 
able to EGE 
Phosphorylation of  EGFR on Threonine 654 
The hydrolysis of polyphosphoinositides, as a result of phos- 
pholipase C activation, leads to protein kinase C (PKC) acti- 
vation by 1,2-diacylglycerol, one of the hydrolytic products. 
One  of the  best  characterized  substrates  for  PKC  is  the 
EGFR.  Phosphorylation of the EGFR by PKC occurs pre- 
dominantly on a threonine residue (threonine 654) located 
close to the plasma membrane (37). This results in a specific 
loss of high affinity EGF binding and a decreased ability for 
EGF-mediated protein-tyrosine kinase activation. Also EGF 
induces threonine 654 phosphorylation (61), thus constitut- 
ing a negative feedback mechanism in the action of the growth 
factor.  In tryptic  phosphopeptide  maps of EGFR  isolated 
from A431  cells  treated  with the  phorbol  ester TPA,  the 
pHi 
A 
7.1  1 
EGF  B 
1MIN 
Figure 7.  pH~ measurements.  A431 (A) and A431-2E9 (B) cells, 
grown on glass coverslips and loaded with BCECF  were treated 
with EGF (50 ng/ml) as indicated. BCECF fluorescence was con- 
tinuously monitored using a fluorimeter. 
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phorylation on residues X, Y, and Z  equaled that in EGF- 
treated control cells (not shown), indicating that in A431-2E9 
cells the same amount of receptors is subject to this feedback 
regulation mechanism. Thus, EGF is able to induce phos- 
phorylation of  the EGFR residue threonine 654, most proba- 
bly via activation of PKC, through binding to high affinity 
receptors only. A  fourth spot (labeled T in Fig.  8 B) was 
identified as  tyrosine  1173, the  major  EGFR  (auto)phos- 
phorylation site (22, 42). 
Figure 8.  Tryptic phosphopeptide maps of EGFR isolated from 
32P-labeled A431 cells. A431-2E9 cells, labeled to equilibrium with 
[a2P]orthophosphate were treated with EGF (B) or not (A). The 
cells were lysed and the EGFR was immunoprecipitated. Subse- 
quently, EGFR was isolated from SDS gels and treated with trypsin 
as described in Materials and Methods. Shown are autoradiographs 
of two-dimensional, high performance, thin-layer chromatograms 
of  the tryptic peptides. X, Y, and Zare peptides containing threonine 
654.  T, the peptide containing tyrosine 1173. O,, the site of appli- 
cation. First dimension, high voltage electrophoresis at pH 8.9 (an- 
ode left, cathode right); second dimension, ascending chromatog- 
raphy. 
phosphopeptides  containing  threonine  654  are  visible  as 
three distinct  spots  that  have been  labeled  X,  Y,  and  Z, 
respectively, by Hunter et al.  (37). 
Incubation  of  32P-labeled  A431  cells  with  mAb  2E9 
yielded  the  same  pattern  of labeled  EGFR tryptic phos- 
phopeptides as  in control cells (map shown for A431-2E9 
cells in Fig.  8 ,4).  Addition of EGF to A431-2E9 cells re- 
suited in the appearance of several new spots (Fig. 8 B). On 
the basis of parallel phosphopeptide maps made from EGFR 
isolated from cells treated with the  PKC-activating tumor 
promoter TPA (not shown), we have identified three of these 
Induction of the c-Fos Protooncogene 
Bravo et al. (8) have shown a rapid induction ofc-fos by EGF 
in A431 cells as well as in subclones of this cell line that are 
not growth inhibited by EGE Accordingly, measurements of 
c-fos expression by RNA blot analysis  (Fig.  9)  showed a 
strong induction of the protooncogene by EGE In A431-2E9 
cells, EGF-induced c-fos expression was as strong as in con- 
trol  cells,  and  occurred with  a  similar  time course  (not 
shown), demonstrating that also in this case, EGF acts pre- 
dominantly via high affinity receptors. 
Fluid-phase Pinocytosis and Morphological Changes 
Fluid-phase pinocytosis (the uptake of small droplets of ex- 
tracellular  medium  via  plasma  membrane  invaginations 
resulting in easily visible, vacuole-like structures) is elicited 
rapidly  in A431  cells by very low concentrations of EGF 
(30), suggesting that it might occur via high affinity EGFR. 
Here, we measured pinocytosis by adding EGF in combina- 
tion with the fluorescent dye fluorescein-complexon to A431 
and A431-2E9 cells.  After incubation at 37°C,  ceils were 
washed and lysed. Fluorescence in the lysates was measured 
at the appropriate wavelength in a fluorimeter. In A431-2E9 
cells,  the  pinocytotic activity  is  drastically  reduced  (not 
shown). This is not due to a previous induction of  pinocytosis 
by the antibody. As for the effects of  mAb 2E9 on EGF-induced 
Ca  2÷ influx, it is unclear at present whether we are dealing 
here with a nonspecific side effect of the antibody or not. 
EGF induces membrane ruffling and rounding up of A431 
cells within minutes (12,  13).  Under Ca2÷-free conditions 
these effects are particularly dramatic,  but also in normal 
medium they can easily be observed.. Chinkers et al.  (12) 
have suggested that fluid-phase pinocytosis and membrane 
ruffling are closely associated. It was therefore of interest to 
determine this effect in A431-2E9 cells.  Fig.  10 A shows a 
phase-contrast image of  A431-2E9 cells, and Fig. 10 B shows 
the same cells after addition of 5 ng/nl of EGF for 10 min 
at 37°C. Clearly, there is extensive cell rounding particularly 
at the edges of colonies, in agreement with the observation 
of Chinkers et al. (12). Thus, EGF-induced cell rounding oc- 
curs via high affinity receptors and in the absence of pinocy- 
tosis. 
Figure 9. Northern blot analysis of c-fos expression. Subconfluent 
A431 cells were treated with the indicated ligands for 30 min fol- 
lowed by cell lysis, extraction of RNA, and Northern blotting. Indi- 
cated are the positions of the 2.2-kb fos mRNA, and 18-S and 28-S 
ribosomal RNAs. lanes 1-3, A431 cells; lanes 4 and 5, A431-2E9 
cells. Ligands added: (lane 1) mAb 2E9;  (lanes 2 and 4) EGF; 
(lanes 3 and 5) TPA. 
Discussion 
EGF receptors exist in two forms on the cell surface of a vari- 
ety of cells.  These subclasses  differ prominently in  their 
binding affinity for EGF, the high affinity EGFR being the 
minor fraction. At present, a direct biochemical identifica- 
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logical  changes. Half-confluent  A431 
and  A431-2E9 cells  were treated 
with EGF (50 ng/ml) for 10 min at 
37°C. A shows a phase-contrast im- 
age of untreated A431-2E9 cells. B 
shows the  same  cells  after  EGF 
treatment. Bar, 50/~m. 
tion of high affinity EGFR is lacking, but a number of data 
apart from Scatchard analysis can be considered as evidence 
for their existence: (a) treatment of cells with agents that ac- 
tivate PKC results in a specific inhibition of EGF binding to 
high affinity receptors, without changing the total receptor 
number (55); (b) treatment of HeLa cells with glucocorti- 
coids leads to a  specific increase in high affinity receptor 
number (25); (c) 3T3 and Chinese hamster ovary cells trans- 
fected with single, EGFR-encoding eDNA sequences display 
both receptor classes (48), but several mutations in the intra- 
cellular domain of such receptors specifically lead to abolish- 
ment of  high affinity sites (44, 48); and (d) the present study, 
along with a number of other reports on EGFR mAbs shows 
that high and low affinity receptors can be recognized on the 
basis of their immunoreactivity. 
The availability of an agent like EGFR-reactive mAb 2E9, 
that  specifically interferes  with  EGF  binding  to  the  low 
affinity subclass, enables investigation of both structural and 
functional parameters of high affinity EGFR. mAb 2E9 is 
not unique in this respect. Antibodies IMG7-IgG, described 
by Behzadian and Shimizu (3), and EGR/G49, described by 
Gregoriou and Rees (29), also specifically block EGF bind- 
ing to low affinity receptors, but only partially. Kawamoto et 
al. (39) reported the presence of a very small (<0.2%) popu- 
lation  of very high  affinity (Kd  7  X  10  -H  M)  EGFR on 
formaldehyde-fixed  A431 cells, based upon saturation curves 
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our bands, however, on unfixed cells preincubation with anti- 
body 528  efficiently blocks binding to both low and high 
affinity receptors. 
In a previous paper (20), we reported that antibody 2E9 
and two other EGFR-reactive mAbs stimulated EGFR pro- 
tein-tyrosine kinase activity in vitro as well as in intact cells. 
However, as shown here for mAb 2E9, when these results 
were reevaluated using the method of phosphoamino acid 
analysis described in Materials and Methods, receptor acti- 
vation by the antibodies was not detected in intact cells. Ad- 
ditional experimental evidence (not shown) indicated that the 
spot originally identified by us as phosphotyrosine in a one- 
dimensional high voltage thin-layer chromatograph was most 
probably uridine monophosphate, present due to hydrolysis 
of RNA contaminating the EGFR immunoprecipitates. There- 
fore, one-dimensional phosphoamino acid analysis at pH 3.5 
may yield unreliable results, even when it is performed on 
immunoprecipitated material from 32p-labeled cells which 
has been subjected to SDS gel electrophoresis. 
The usefulness of antibody 2E9  in the analysis of high 
affinity EGFR receptors becomes even more apparent when 
it is realized that such studies cannot be made by using low 
concentrations of EGF with the idea of specifically occupy- 
ing high affinity sites.  One can calculate that even at ex- 
tremely low concentrations of EGF (<0.01 nM), a substantial 
amount (~35 %) will bind to low affinity sites. An additional 
problem is that under such circumstances only a very small 
part of the total high affinity receptor population will be oc- 
cupied (*5 % at equilibrium). Studies in which low amounts 
of EGF are used to measure high affinity receptor-mediated 
effects (49)  should therefore be  interpreted  with caution. 
Blocking low affinity sites with mAb 2E9 makes it possible 
not only to specifically saturate the remaining high affinity 
receptors, but also to achieve this rapidly with a high dose 
of EGE We realize that this approach is also subject to criti- 
cism. At the standard concentration of mAb 2E9 used in our 
experiments (300 nM), only 90 % of the maximal amount of 
antibody binding sites are occupied, given its Ko of 32 nM. 
Furthermore, our data do not rule out the possibility that 
mAb 2E9 itself might influence the behavior of high affinity 
receptors. However,  in comparison with EGF binding data 
obtained in the absence of mAb 2E9, the antibody does not 
disturb EGF binding to the high affinity subclass, even after 
a prolonged incubation with supersaturating amounts of anti- 
body (1,200 nM for 3 h, not shown). 
Our data indicate that in A431 cells, high affinity receptors 
are the major subpopulation through which receptor activa- 
tion occurs: while mAb 2E9 effectively blocks EGF binding 
to 95 % of the surface-exposed receptor population, EGF is 
still capable of causing the major part of surface-exposed 
receptors  to become phosphorylated on tyrosine residues 
(70% of the amount phosphorylated in control cells). Since 
the high affinity  receptor subpopulation alone is far too small 
to account for at least 70% of the autophosphorylation signal 
(see Results), phosphorylation of low affinity receptors has 
to occur, even when they are inaccessible to EGE We have 
considered  the possibility that high affinity receptors  are 
very rapidly internalized and replaced by new receptors, thus 
accounting for more than the apparent 5 % of membrane- 
exposed receptors. However, the same results were obtained 
when mAb 2E9-treatexi  cells were incubated with EGF at 
0°C (data not shown), a temperature at which internalization 
does not occur (63),  in contrast to EGF-induced dimeriza- 
tion (16). 
The  results  obtained in  surface-labeled cells  show that 
EGFR dimer formation can be driven through high affinity 
receptors only. Furthermore, the data obtained using radiola- 
beled  EGF and DSS  as cross-linking agent,  indicate that 
high affinity receptors contain dimers as well as monomers. 
In the present study, receptor kinase activation was mea- 
sured  as  an  increase  in  tyrosine phosphorylation of the 
receptor itself, which is commonly referred to as autophos- 
phorylation (i.e., intramolecular). However, recent observa- 
tions suggest that (auto)phosphorylation might occur through 
intermolecular cross-phosphorylation: Stern and Kamps (57) 
and King et al.  (41) reported that the c-erbB2/neu proto- 
oncogene product p185 "° becomes cross-phosphorylated on 
tyrosine residues when EGF is added to cells in which both 
this protein and the EGFR are expressed. P185  ~" and EGFR 
share an extensive overall structural homology (18). Further- 
more, the cross-phosphorylation of p185 ~" by EGFR occurs 
with similar kinetics as receptor (auto)phosphorylation (57). 
Direct evidence for intermolecular EGFR cross-phosphory- 
lation was recently obtained by J. Schlessinger and co-workers 
using 3T3 cells that were double transfected with two mu- 
tated EGFR sequences (34). In combination, the results lead 
us to propose that, at least in intact A431 cells, EGF induces 
intermolecular activation of low affinity receptors by high 
affinity receptors through the formation of oligomers between 
the two receptor types; i.e., cross-phosphorylation. 
In addition, we have analyzed the effects of blocking low 
affinity EGFR by mAb 2E9 on the early EGF-induced signal 
transduction cascade. The results are quite straightforward. 
Exclusive EGF binding to the high affinity EGFRs leads to 
responses  qualitatively and quantitatively similar to those 
normally observed. These responses include all secondary 
effects tested that have been linked before to second mes- 
senger production resulting from the breakdown of phos- 
phoinositides by phospholipase C activation. These are (a) 
InsPn production,  (b)  Ca  2÷  mobilization,  (c)  Na÷/H ÷ ex- 
change activation, (d) phosphorylation of threonine residue 
654 of the EGFR, and (e) induction of c-fos gene expression. 
Other cellular responses that occur normally in the presence 
of mAb 2E9 are EGF internalization and cell rounding. The 
only exceptions found are the inhibition of Ca  2÷ influx and 
fluid-phase pinocytosis. Pinocytosis is a rapid and transient 
event in A431 cells (30).  It involves uptake of relatively large 
amounts of extracellular fluid and therefore the EGF-induced 
Ca  ~÷ influx may be a direct consequence of this event. How- 
ever, we render it likely that these are nonspecific side effects 
of  the antibody in combination with EGF, but direct evidence 
hereto is lacking. 
In conclusion, our present results for the first time provide 
direct evidence for a major role of high affinity EGFR in the 
complex process of early intracellular signal transduction. 
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